Effect of PCSK-9 Inhibitors on Lipid-Rich Vulnerable Coronary Plaque Assessed by Near-Infrared Spectroscopy.

Hiroyuki Omori,Hideaki Ota,Masahiko Hara,Yoshiaki Kawase,Toru Tanigaki,Tetsuo Hirata,Yoshihiro Sobue,Munenori Okubo,Hiroki Kamiya,Hitoshi Matsuo

JACC: Cardiovascular Imaging（2020）

引用 14|浏览48

暂无评分

摘要

Patients with acute coronary syndrome (ACS) face a substantial risk of future adverse cardiovascular events, including recurrent ACS ([1][1],[2][2]). Because this risk is partly attributable to lipid-rich vulnerable plaque, high-intensity statin therapy is recommended as a secondary prevention

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要